Product information and disease descriptionPlace of product in therapyDisease description
Diagnosis
9 evidence topics · 12 sources
Clinical diagnostic criteria: 2010 consensus criteria for typical and atypical Rett syndrome
“We limited the necessary criteria to the presence of regression plus four main criteria that are absolutely required for the diagnosis of typical RTT.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“In these new criteria, history of regression and ALL of the necessary and exclusion criteria MUST be met to make the diagnosis of typical RTT, without exception.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“we state that for the diagnosis of atypical RTT an individual MUST have a period of regression followed by recovery or stabilization.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Young children: provisional diagnosis before regression is evident
“Because MECP2 mutations are now identified in some individuals prior to any clear evidence of regression, the diagnosis of” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“RTT should be given to those individuals under 3 years old who have not lost any skills but otherwise have clinical features suggestive of RTT. These individuals should be reassessed every 6–12 months for evidence of regression. If regression manifests, the diagnosis should then be changed to definite RTT. However, if the child does not show any evidence of regression by 5 years, the diagnosis of RTT should be questioned.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Validation of the criteria in the US Natural History Study: 819 participants
“The present analysis was conducted on 819 participants enrolled as of February 28, 2010, to assess the recently modified clinical criteria.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Of 765 females fulfilling criteria for classic or variant RTT, 653 (85.4%) were diagnosed as classic and 112 (14.6%) were classified as variant. A mutation was identified in 95% of 653 females with classic and 73.2% of 112 females with variant RTT” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Abnormal deceleration in the rate of head growth was noted in 82%” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“For classic RTT, these core criteria are sufficient for diagnosis as none of the eight 2002 supportive criteria is noted uniformly. For variant RTT, diagnosis requires application of both main (2 of 4) and supportive (5 of 11) criteria.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Genetic testing: MECP2 sequencing with deletion and duplication analysis
“For suspicion of RTT, MECP2 gene sequencing and MLPA testing are recommended. MLPA testing is needed to detect deletions otherwise missed by sequencing; this test is necessary if no abnormalities are found by sequencing. Referral to a geneticist or genetic counsellor is recommended to review recurrence risks and answer related questions. Genetic testing results are essential for enrolment in clinical trials.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Complete genetic testing involves sequencing and methods to detect larger deletions (eg, multiplex ligation-dependent probe amplification) of the MECP2 gene.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Second, thorough and complete genetic testing for mutations in MECP2 should be performed on all participants. This would include sequencing of the coding region as well as methods such as MLPA, quantitative PCR, microarray methods, or Southern blotting to detect large DNA rearrangements.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Genetic testing: diagnostic yield of next-generation sequencing in 1,577 patients with a Rett-like presentation
“We studied 1577 patients with RTT-like clinical diagnoses and reviewed patients who were previously studied and thought to have RTT genes by Sanger sequencing. Genetically, 477 of 1577 patients with a RTT-like suspicion have been diagnosed. Positive results were found in 30% by Sanger sequencing, 23% with a custom panel, 24% with a commercial panel and 32% with whole exome sequencing.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Genetic testing: missed variant after repeated sequencing
“Here, we describe a young woman with clinically diagnosed Typical RTT syndrome who lacked a genetic diagnosis despite 20 years of investigation and multiple rounds of sequencing the MECP2 gene.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“This case illustrates the evolving landscape of genetic testing technologies and the limitations of Next Generation (NextGen) sequencing due to deletions, duplications and insertions.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Age at diagnosis: US Natural History Study, 1,085 participants
“Among 919 classic and 166 atypical RTT participants, median diagnosis age was 2.7 years (interquartile range 2.0–4.1) in classic and 3.8 years (interquartile range 2.3–6.9) in atypical RTT. Pediatricians made the diagnosis of classic RTT rarely (5.2%); however, proportion diagnosed by pediatricians increased since 2006.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“33% with microcephaly before 2.5 years were diagnosed after the median age of 2.7 years.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Age at diagnosis: international caregiver survey, 756 caregivers
Age at diagnosis: trends and predictors of delay in Australian and international registries
“The median age of Rett syndrome diagnosis decreased from 4.5 years if diagnosed before 2000 to 3.5 years if diagnosed after 1999.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“A total of 909 cases were included. An older age of diagnosis was associated with later loss of hand function and speech, later onset of hand stereotypies and the presence of the p.R133C or p.R294X MECP2 mutation.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Cases with a p.R133C mutation (adjusted mean 76.5 months) and those with a p.R294X mutation (adjusted mean 69.6 months) had a later age of diagnosis compared to those with a p.T158M mutation (adjusted mean 50.5 months).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote